Author | Guideline criteria used | Estimated prevalence (%) |
|---|
IFG or IGT | IFG | IGT | IFG and IGT | HbA1C | HbA1C and IFG |
|---|
Karve [22] | ADAa | 19.8 | 4.5 | 11.8 | 3.5 | – | – |
ADA†| 34.6 | 19.4 | 5.4 | 9.8 | – | – |
Yip [14] | ADA†| – | 53.1 | 23.8 | 20.2 | – | – |
WHO | – | 36.0 | 45.5 | 15.8 | – | – |
Blum [23] | ADA†| – | 3.0 | – | – | 24.7 | 3.2 |
- a1997 guidelines, FPG: 6.1–6.9 mmol/L (110–125 mg/dL); †post 2003 guidelines, FPG: 5.6–6.9 mmol/L (100–125 mg/dL)
- ADA American Diabetes Association, FPG Fasting plasma glucose, HbA1C, glycated haemoglobin; IFG Impaired fasting glucose, IGT Impaired glucose tolerance, WHO World Health Organization
